Financial News Feed

Stronger Sell Today ABMD ranks #4745 as SELL CANDIDATE. Weaker Sell
Today ABMD ranks #4745 as SELL CANDIDATE.

ABMD stock ABIOMED

ABMD stock
ABIOMED

Cabot Wealth Management Inc decreased Abiomed Inc (ABMD) stake by 59.66% reported in 2018Q4 SEC filing. Cabot Wealth Management Inc sold 2,479 shares as Magna International Inc (NYSE:MGA) had a decrea...

Read more

ABIOMED (ABMD) Stock Price Down 8.7%
09:00pm, Tuesday, 26'th Mar 2019
ABIOMED, Inc. (NASDAQ:ABMD) shares were down 8.7% on Tuesday . The company traded as low as $284.63 and last traded at $286.00. Approximately 1,959,470 shares changed hands during mid-day trading, an ...

Read more

ABIOMED (ABMD) Trading Down 8.7%
09:00pm, Tuesday, 26'th Mar 2019
ABIOMED, Inc. (NASDAQ:ABMD) dropped 8.7% during mid-day trading on Tuesday . The stock traded as low as $284.63 and last traded at $286.00. Approximately 1,959,470 shares traded hands during trading, ...

Read more

Big Money Sentiment increased to 1.22 in Q4 2018. It has change of 0.01, from 2018Q3's 1.21. The ratio improved due to ABMD positioning: 48 sold and 129...

Read more

How To Gain With ABIOMED, Inc. (NASDAQ:ABMD)
07:38pm, Tuesday, 26'th Mar 2019
When stock prices are falling, the best mindset to have is a long term one. High quality stocks such as ABIOMED, Inc. has fared well over time in a fickle Read More......

Read more

Abiomed Inc (ABMD) shares opened the last session at 321.30, touching a high of 322.14 and a low of 313.00 , yielding a change of -9.99. The latest reading places the stock below the Ichimoku cloud wh...

Read more

A recent look at ownership and volatility brings us to a 0.02960 target portfolio weight (as a decimal) for ABIOMED, Inc. (NasdaqGS:ABMD) Target weight is the volatility adjusted recommended stock pos...

Read more

Crawford Investment Counsel Inc increased Sterling Bancorp Del (STL) stake by 18.56% reported in 2018Q4 SEC filing. Crawford Investment Counsel Inc acquired 116,027 shares as Sterling Bancorp Del (STL...

Read more

Thrivent Financial for Lutherans raised its stake in ABIOMED, Inc. (NASDAQ:ABMD) by 174.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (...

Read more

Abiomed Inc (ABMD) investors sentiment increased to 1.22 in Q4 2018. It’s up 0.01, from 1.21 in 2018Q3. The ratio is more positive, as 216 hedge funds opened new or increased positions, while 177 re...

Read more

Dorsey Wright & Associates decreased Abiomed Inc Com (ABMD) stake by 69.37% reported in 2018Q4 SEC filing. Dorsey Wright & Associates sold 17,447 shares as FUJITSU GENERAL LTD ORDINARY SHARES JAP (OTC...

Read more

Taking a look at shares of ABIOMED, Inc. (NASDAQ:ABMD), we can see that the average consensus target price based on contributing analysts is currently $442.29. Sell-side analysts often provide price t...

Read more

Sell-side analysts are offering a consensus “Buy” rating on shares of ABIOMED, Inc. (NASDAQ:ABMD). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sel...

Read more

Traders purchased shares of ABIOMED, Inc. (NASDAQ:ABMD) on weakness during trading hours on Monday. $73.70 million flowed into the stock on the tick-up and $52.19 million flowed out of the stock on th...

Read more

ABIOMED, Inc. (NASDAQ:ABMD) currently has an Average Broker Rating of 1.11. This number is based on the 9 sell-side firms polled by Zacks. The ABR rank within the industry stands at 18. Analysts often...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank